MEDISTIM ASA: årsregnskap 2025 vs 2024
Grew 25% on revenue, weaker earnings, cash halved-plus
approved 2026-05-06; registry 2026-07-30; journal 2026 649007
Summary
What changed
Comparing Årsregnskap 2025 with 2024 for MEDISTIM ASA. Revenue 354.0k NOK → 442.6k NOK (+25.0%). Net result +103.31m NOK → +146.0k NOK. Equity 209.19m NOK → 204.70m NOK.
On the constructive side: revenue rose; operating result improved; owners injected capital. Pressures included: net result weakened; equity eroded; cash fell.
Also worth watching: sharp cash drawdown; cogs moved; book investments changed. All figures are taken from the published annual accounts for MEDISTIM ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 354.0k NOK to 442.6k NOK (+25.0% YoY). Calculated
-
↑
Operating result improved
Operating result +110.3k NOK → +151.0k NOK (op. margin 31.2% → 34.1%). Calculated
-
↑
Owners injected capital
Paid-in equity rose 319.1k NOK → 67.58m NOK (+67.26m NOK). Reported fact
What deteriorated
-
↓
Net result weakened
Net result +103.31m NOK → +146.0k NOK (net margin 29179.9% → 33.0%). Calculated
-
↓
Equity eroded
Book equity 209.19m NOK → 204.70m NOK (equity ratio 44819.7% → 39289.8%). Calculated
-
↓
Cash fell
Bank deposits 126.88m NOK → 153.2k NOK (-99.9% YoY). Calculated
Things to notice
-
·
Sharp cash drawdown
Cash fell by more than 60% YoY (126.88m NOK → 153.2k NOK). Check whether funds moved to group receivables, investments, or operating burn. Interpretation
-
·
COGS moved
COGS / varekostnad 3.11m NOK → 3.13m NOK (+0.5% YoY). Calculated
-
·
Book investments changed
Investment / intangible book value 51.16m NOK → 49.45m NOK. Reported fact